Kaya 959 Kaya Biz

Dis‑Chem's FY2026 Mixed as Revenue Climbs, Earnings Dip

Loading player...
Dis‑Chem CEO Rui Morais unpacks a results set showing strong revenue growth but pressure on headline earnings. He explains the Group’s R445m investment into its healthcare ecosystem, the performance of Better Rewards, margin pressure in dispensary and wholesale, and how the Store of the Future will reshape customer experience and profitability.
1 Jun 3PM English South Africa Business News · Investing

Other recent episodes

Can You Trust AI for High-Stakes Decisions?

Should you rely on AI for critical legal or financial choices? My AI Lawyer Head of Services Michael Visser joins Nzinga Qunta to unpack how specialized AI acts as an affordable starting point to navigate your rights before paying for professional advice.
5 Nov 1PM 13 min

How to Invest in Banana Trees

Expanding beyond traditional livestock, crowdfarming is now giving everyday South Africans direct access to plant-based farm assets. Ntuthuko Shezi breaks down the mechanics of banana tree investments, harvest yield returns, and risk management for retail investors looking to grow real farm wealth.
5 Nov 1PM 15 min

FlySafair’s R7bn Deal Approved

Following the Competition Tribunal’s approval of Harith’s takeover of FlySafair, aviation analyst Guy Leitch joins KayBiz to unpack market concentration, cross-ownership with Lanseria Airport, and the impact on domestic ticket prices.
5 Nov 12PM 8 min

Reshaping Philanthropy

Operating globally, the Black Feminist Fund is challenging traditional donor models. We unpack how flexible core funding and participatory grantmaking shift capital and long-term institutional power directly to grassroots movements.
5 Nov 12PM 16 min
All episodes